Education
About Us
Working with TipRanks
Follow Us
ABLG - ETF AI Analysis
Top Page
Abacus Fcf International Leaders Etf (ABLG)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Leading Holdings
Several of the largest positions, especially in technology and health care, have shown strong gains so far this year, helping support the fund’s overall results.
Sector Diversification
The ETF spreads its investments across multiple sectors such as technology, consumer, health care, and industrials, which can help reduce the impact if one industry struggles.
Growing, Mid-Sized Fund
With a moderate level of assets under management, the fund is large enough to be established while still being small enough to remain flexible in its stock selection.
Negative Factors
High U.S. Concentration
Despite its international focus, the fund is heavily tilted toward U.S. exposure, limiting the benefits of global diversification.
Mixed Performance Among Top Holdings
A few of the larger positions have shown weak or negative performance this year, which can drag on the ETF’s overall returns.
Above-Average Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, meaning more of the gross return is lost to fees each year.
ABLG vs. SPDR S&P 500 ETF (SPY)
AUM26.76M
RegionGlobal Ex-U.S.
Expense Ratio0.54%
Beta0.71
IssuerAbacus
Inception DateJun 27, 2017
Dividend Yield2.23%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume17,390
30 Day Avg. Volume4,907
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ABLG Summary
The Abacus Fcf International Leaders ETF (ABLG) invests in leading companies outside the U.S. that generate strong free cash flow, which can be a sign of solid, steady businesses. It does not track a specific index, but follows a theme of owning high-quality international firms across many sectors, with a tilt toward technology, health care, and consumer brands. Well-known holdings include TSMC and Novartis. An investor might choose this ETF for international diversification and long-term growth potential. A key risk is that international stocks and currencies can be volatile, so the value can go up and down significantly over time.
How much will it cost me?The Abacus Fcf International Leaders ETF (ABLG) has an expense ratio of 0.54%, which means you’ll pay $5.40 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on selecting companies with strong free cash flow rather than tracking a broad index.
What would affect this ETF?The Abacus Fcf International Leaders ETF could benefit from global economic growth, particularly in sectors like technology and healthcare, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates or regulatory changes in key international markets, which could impact the profitability of its top holdings like TSMC and Novartis. Additionally, currency fluctuations and geopolitical tensions could negatively affect its global ex-U.S. exposure.
ABLG Top 10 Holdings
ABLG is leaning heavily on global tech, with chip names like TSMC and Advantest doing much of the heavy lifting as they ride strong demand for AI and advanced semiconductors. Health care is the fund’s other key engine: Roche, Novartis, and Jazz Pharmaceuticals have been generally rising, though Jazz’s earlier stumbles mean it’s more of a comeback story. On the consumer side, LVMH is losing steam while L’Oréal looks steadier, creating a mixed picture. Overall, it’s a global ex-U.S. portfolio, but clearly tilted toward cash-rich tech and pharma leaders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Advantest | 7.14% | $1.91M | $123.58B | 186.10% | 59 Neutral | |
| TSMC | 5.54% | $1.48M | $1.58T | 79.68% | 81 Outperform | |
| Novartis | 4.05% | $1.08M | $309.48B | 52.99% | 80 Outperform | |
| Roche Holding | 3.89% | $1.04M | $374.01B | 43.23% | 74 Outperform | |
| AstraZeneca | 3.18% | $851.93K | $319.11B | 31.68% | 80 Outperform | |
| Telefonaktiebolaget LM Ericsson | 2.89% | $774.35K | $36.68B | 39.95% | 74 Outperform | |
| H World Group | 2.72% | $728.46K | $15.97B | 43.48% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton SE | 2.70% | $721.81K | $302.72B | -16.94% | 75 Outperform | |
| Advanced Info Service PCL | 2.64% | $705.43K | $37.05B | 43.44% | 67 Neutral | |
| Ambev SA | 2.57% | $688.20K | $49.16B | 61.26% | 80 Outperform |
ABLG Technical Analysis
Positive
―
Price Trends
32.20
Positive
31.62
Positive
30.82
Positive
Market Momentum
0.11
Positive
51.36
Neutral
59.90
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ABLG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.51, equal to the 50-day MA of 32.20, and equal to the 200-day MA of 30.82, indicating a bullish trend. The MACD of 0.11 indicates Positive momentum. The RSI at 51.36 is Neutral, neither overbought nor oversold. The STOCH value of 59.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ABLG.
ABLG Peer Comparison
Comparison Results
Performance Comparison
ABLG
Abacus Fcf International Leaders Etf
32.55
2.54
8.46%
AADR
AdvisorShares Dorsey Wright ADR ETF
―
―
―
PJIO
PGIM Jennison International Opportunities ETF
―
―
―
TIER
T. Rowe Price International Equity Research ETF
―
―
―
VNIE
Vontobel International Equity Active ETF
―
―
―
ESIM
Eventide International ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents